Avorelin, formerly known as EP-23904, MF-6001, Meterelin, is a luteinizing hormone releasing hormone (LH-RH) agonist potentially for the treatment of prostate. References: Kaisary AV, Bowsher WG, Gillatt DA, Anderson JB, Malone PR, Imbimbo BP. Pharmacodynamics of a long acting depot preparation of avorelin in patients with prostate cancer. Avorelin Study Group. J Urol. 1999 Dec;162(6):2019-23. PubMed PMID: 10569560.

纯度：≥98%

CAS：140703-49-7